tiprankstipranks
Trending News
More News >
Larimar Therapeutics, Inc. (LRMR)
:LRMR
US Market
Advertisement

Larimar Therapeutics (LRMR) Financial Statements

Compare
908 Followers

Larimar Therapeutics Financial Overview

Larimar Therapeutics's market cap is currently $436.51M. The company's EPS TTM is $-0.41; its P/E ratio is ―; Larimar Therapeutics is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Larimar Therapeutics Earnings and Revenue History

Larimar Therapeutics Debt to Assets

Larimar Therapeutics Cash Flow

Larimar Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis